A Study of Metformin With or Without Rapamycin as Maintenance Therapy After Induction Chemotherapy in Subjects With Pancreatic Cancer
Conditions
- Metastatic Pancreatic Adenocarcinoma
Interventions
- DRUG: metformin alone (Arm A)
- DRUG: metformin (Arm B)
- DRUG: rapamycin (Arm B)
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators